Investor Ideas Potcasts, Cannabis News and Stocks on the Move; (TSXV: VGW) (OTCQX: VGWCF) (TSX: WEED) (NYSE: CGC) (TSXV: NRTH)
Delta, Kelowna, BC - December 12, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts, #Cannabis News and #Stocks on the Move; (TSXV: VGW) (OTCQX: VGWCF) (TSX: WEED) (NYSE: CGC) (TSXV: NRTH)
Today's podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today's podcast we look at a few early announcements.
Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF) announced that it has entered an amended manufacturing and sales licence agreement with SōRSE Technology Corporation which grants Valens an exclusive licence for Canada, Europe, Australia and Mexico to use the proprietary SōRSE emulsion technology to produce, market, package, sell and distribute cannabis-infused products.
"This Agreement shows Valens' commitment to invest and broaden its IP portfolio and enable its customers to bring differentiated, next generation products to market," said Jeff Fallows, President of Valens. "As we move into "Cannabis 2.0" in Canada, we believe the products that offer consistent, high quality and predictable user experiences, like those we are able to create with SōRSE, will capture the lion's share of attention and be the hallmark for brand development in a strict regulatory environment. With this expanded agreement in place, we have extended this opportunity for our existing customers to key international markets and at the same time established a platform for international consumer brands to add high quality, cannabis infused products to their portfolios."
The SōRSE emulsion technology transforms cannabis oil into water-soluble forms for use in beverages, edibles, topicals and other consumer products without the burden of cannabis taste, colour or smell. The Technology allows these cannabis infused products to maintain potency when heated, chilled or frozen and provides a number of other key advantages as well, including: (1) a faster observed onset time compared to other infused beverages and edibles, (2) a significant reduction of offset time, (3) an ability to use lower doses of cannabinoids due to the enhanced bioavailability provided by the Technology, and (4) increased consistency and stability with some product formulations achieving more than one-year shelf stability with no evidence of separation.
"We are proud to expand our partnership with Valens and leverage their near-term access to various global markets," says Howard Lee, CEO of SōRSE. "Over the last year, our team of more than 40 plus professionals has continued to actively focus on creating and developing innovative, desirable products and formats of consumption for cannabis consumers. As emulsion technology becomes more popular through new delivery methods such as ingestion, transdermal, topical and more, it is imperative that quality and safety in consumption leads all innovation in this sector. This is a shared value and mandate that our teams at SōRSE and Valens both prioritize. We look forward to continuing this working relationship with Valens and introducing our award-winning emulsion technology to the global markets."
The Agreement grants Valens an exclusive licence to use the Technology in Canada, Europe, Australia and Mexico (except in respect of medical applications requiring clinical trials) during the initial 5-year term, subject to certain performance milestones. This increases the addressable market from 37 million in the current Canada only agreement to 700 million people in the new Agreement, an increase of almost 20x. Furthermore, the Agreement provides a framework for Valens to obtain rights to establish non-exclusive agreements to sell cannabis-infused products using the Technology in the U.S. market and other markets, globally.
Canopy Growth Corporation, USA, LLC (TSX: WEED) (NYSE: CGC) today announced the launch of First & Free - a hemp-derived CBD product line offered in a variety of formats, including softgels, oil drops and creams. The products will be available for purchase on the company's first e-commerce site: www.firstandfree.com.
Perfected through state-of-the-art technology and rigorous testing, First & Free products are created by extracting and isolating derivatives from the hemp plant to produce pure and consistent CBD formulations that are packaged in easy-to-use formats.
"First & Free marks a new way for US consumers to purchase quality CBD products from a trusted source," said Rade Kovacevic, President, Canopy Growth. "Through state-of-the art extraction methods, strict quality control measures, and scientific research, we are delivering a best-in-class product to the market."
At launch, the First & Free brand will offer the following hemp-derived CBD products:
- First & Free Oil Drops
- Unflavored 25 mg per mL (750 mg per 30 mL bottle)
- Peppermint flavor 25 mg per mL (750 mg per 30 mL bottle)
- First & Free Softgels
- 250 mg CBD carton (10 softgels)
- 750 mg CBD bottle (30 softgels)
- 1500 mg CBD bottle (30 softgels)
- First & Free Creams*
- 2500 mg Everyday Cream (CBD Only)
- 2500 mg Motion Cream (CBD + Arnica)
- 2500 mg Revitalize Cream (CBD + Capsaicin)
Canopy Growth is committed to selling only high-quality, tested and reliable products, and ensuring it makes no claims unless clinically validated. This means selling First & Free products only in states where permissible under state law in order to ensure compliance with state consumer protection mandates and following the most stringent state laws regarding sale of CBD. The Company is also abiding by existing FDA regulations for manufacturing, labeling and marketing dietary supplements.
Sundial Growers Inc. (NASDAQ: SNDL) announced the launch of Top Leaf-a new brand of premium, rich, and full-bodied cannabis products. Created by and for cannabis enthusiasts and connoisseurs, consumers will not only be able to enjoy the highest quality cannabis in traditional flower and pre-roll formats, but in new vape formats as well.
"Consumers have long-awaited access to genetically unique and premium cannabis since legalization. We are excited to provide the true cannabis lover with the products they've been looking for," said Ryan Hellard, Chief Experience Officer of Sundial. "Top Leaf is a significant achievement for Sundial as we continue to distinguish ourselves as a global leader in the industry. This is an essential part of the overall Sundial brand and product portfolio, as it offers even the most discerning cannabis consumer products that are a cut above the competition."
Top Leaf cultivars start with a mix of famous and exclusive genetics from around the world. Each strain is grown in small batches by master growers in purpose-built modular rooms at Sundial's flagship facility in Olds, Alberta.
Top Leaf will offer products in four series:
- The Black Series-strong and unique flavors with a variety of interesting terpene profiles
- The Masters Series-unique strains that are rare and notoriously difficult to grow
- The Legends Series-a modern take on famous cannabis classics
- The Untamed Series- original landrace strains cultivated in their natural environment from around the world
The Black and Legends Series will be the first to debut under the Top Leaf brand. Strawberry Cream, an-award winning Sundial exclusive strain with a unique flavor profile, and renowned classic GSC will be the first Top Leaf products available in retail stores. The product lineup will continue to expand in 2020 with a mix of original and classic strains including Oregon Golden Goat, Super Skunk and Blue Dream. Cannabis enthusiasts can also look forward to the award-winning sativa, Sweet J, in the new year.
Top Leaf products will initially ship to Alberta, British Columbia and Nova Scotia, and will later enter Saskatchewan, Manitoba, Ontario and P.E.I. by the end of the year. Top Leaf joins Palmetto and Sundial's namesake cannabis brand, enhancing the company's portfolio of craft cannabis brands that help our consumers to Heal, Help and Play.
For more information about Top Leaf, visit www.topleaf.ca and follow us on Instagram @topleafcanada.
Recently, the Company announced that it completed its first outdoor harvest at Good:Farm and hit its production cost targets, placing 48North among the lowest-cost producers of legal cannabis in Canada. This year's harvest positions the Company to deliver on its supply agreements with provincial wholesalers in Alberta, Ontario and Quebec and extraction supply for humble + fume.
Today's announcement of cannabinoid testing results reinforce 48North's strong position heading into 2020. The analysis - which was completed by A&L Canada Laboratories Inc. - reported the following results:
- The THC content of the four cannabinoid rich strains that 48North successfully harvested at Good:Farm ranges from 11% to 19% with a weighted average of 14%. These strains (Nepal Lights, Mountain Kush, Lemon Haze, and Green Crack) are expected to be used to fulfill 48North's dried flower commitments to provincial wholesalers.
- The THC content of the cannabinoid rich biomass produced at Good:Farm has more variation in the cannabis levels, and ranges from 2% to 15% with a weighted average of 12% (with 69% of the biomass showing THC levels of 14%). This biomass will be used to supply humble+fume to develop the suite of next-generation products such as vapes and topicals.
48North has received notification that provincial wholesalers will be selling the Company's next-generation cannabis products beginning in early 2020, including the Avitas vape, the Apothecanna topical line, and Mother + Clone sublingual products. Further, 48North believes its vape SKUs in partnership with humble + fume will represent approximately 10 per cent of overall vape market listings in Ontario, a market that is is projected to be as large as $600 million by 2021.
"We are very proud to confirm that we have successfully delivered high-quality cannabis at a low per-gram cost in our first year of outdoor production. While disappointed, that we harvested less cannabis than projected in our first year at Good:Farm, today's results are clear evidence of 48North's industry leadership in the cultivation and production of outdoor-grown cannabis. We look forward to incorporating the lessons learnt this year at Good:Farm and applying them to ensure the 2020 harvest season is a success." said Alison Gordon, CEO of 48North.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android